A Study of Oral LOXO-292 (Selpercatinib) in Pediatric Participants With Advanced Solid or Primary Central Nervous System (CNS) Tumors

The Children's Hospital at Westmead, Westmead

Rigshospitalet, Copenhagen

Royal Children's Hospital, Melbourne

Hospital Universitari Vall d'Hebron, Barcelona

Memorial Sloan Kettering Cancer Center, New York

Children's Hospital of Philadelphia, Philadelphia

Fondazione IRCCS Istituto Nazionale dei Tumori, Milan

Nemours Children's Health, Orlando

St. Jude Children's Research Hospital, Memphis

University of Minnesota Hospital, Minneapolis

Universitätsklinikum Heidelberg, Heidelberg

Texas Childrens Hospital, Houston

The Children's Hospital for Cancer and Blood Disorders, Aurora

Childrens Hospital of Los Angeles, Los Angeles

Gustave Roussy, Villejuif

Seattle Children's Hospital Research Foundation, Seattle

Dana-Farber Cancer Institute, Boston

Cincinnati Children's Hospital Medical Center, Cincinnati

University of Texas Southwestern Medical Center at Dallas, Dallas

The Hospital for Sick Children, Toronto

Hokkaido University Hospital, Sapporo

National Cancer Center Hospital, Chuo-ku

Hiroshima University Hospital, Hiroshima

Kyoto University Hospital, Kyoto

Seoul National University Hospital, Seoul

University College Hospital - London, London